Press release
Orphan Drugs Market: Companies View Discovery of New Diseases Pivotal to Growth of Global Market
Currently, bridging the gap between the cost of producing drugs for diseases that have a low prevalence and profiting from them is the Herculean hurdle for the vendors in the global market. The report analyzes the various technological advancements and growing investments in the research and development of such drugs.
Download Exclusive Sample of this Report: http://bit.ly/2dQ8dCi
The drugs designed and manufactured to treat diseases that are rare are known as orphan drugs. The market is slowly finding its footing as countries are struggling to classify orphan diseases. Presently, the United States has 200,000 such diseases, whereas Japan has 50,000 cases only. These drugs as also known as “niche drugs” as they have opened up avenues for big players to offset their losses due to patent expiration and reducing pipelines. Thus, analysts predict that orphan drugs could open up new business avenues for the pharmaceutical companies.
The global orphan drugs market is also winning support from the supportive regulatory framework in countries such as Singapore, Japan, Australia, and the United States. Some of the countries in the European Union have specific provisions for governing the orphan disease market. The global market is thriving due to the growing interest in understanding the rare conditions, generous grants toward research and development of these drugs, fast-track clinical trials, prolonged exclusivity, and favorable reimbursement options.
Presently, the global orphan drugs market holds a 6% share in the overall pharmaceutical market. Analysts predict that the growing demand for these drugs will boost the share further in the coming years. The research report segments the market on the basis of geography into North America, Asia Pacific, Europe, and the Rest of the World to understand the region-specific market drivers and restraints. The thorough research provides an up-to-date analysis of the ongoing trends as well.
Browse Research Report: http://bit.ly/2dXqAKs
Some of the leading players operating in the global orphan drugs market are Pfizer, Genentech, Janssen Biotech, Inc., Sanofi Aventis, Amgen, Inc., and Abbott Laboratories. The research report provides an analysis of the competitive landscape of the global orphan drugs market along with assessing the business strategies of these players.
The report also includes an understanding of the marketing strategies that these companies are anticipated to rely on in the near future. The research report includes recommendations by market experts as a guide to making well-informed business decisions.
About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Orphan Drugs Market: Companies View Discovery of New Diseases Pivotal to Growth of Global Market here
News-ID: 370470 • Views: …
More Releases from TMR - Research Reports
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during…
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the…
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016.
The global dental membrane and bone graft substitutes market is expected to…
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period.
By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment…
More Releases for Transparency
transparency market research
The global Custom Antibody Market market is estimated to attain a valuation of US$1 Billion by the end of 2033, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 0.085% during the forecast period, 2023 to 2033.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading…
Transparency Market Research
A belt drive is a type of power transmission device which is a looped belt wound around a pair of pulley so as to transmit power between two or more rotating shafts. Compared to other power transmitting devices, belt drives are more preferred in mechanical industry due to easy installation, numerous speed ratio selections, less power loss and comparative low price. Belt drive protects the rotating machinery from overload fluctuations…
Transparency Market Research
An ultrasonic motor is an electric motor which is driven by the ultrasonic vibration of a component. The stator of the motor is supported by piezoelectric components in ultrasonic frequency range which produces different types of vibrations depending on its arrangement. In other words, ultrasonic motor is a type of electric motor that transforms ultrasonic physical vibrations to linear motion, produced by a piezo-transducer. Ultrasonic motors therefore do not use…
More transparency in Engineering IT
CPO certification helps evaluate openness of IT systems
Digitalization is making openness in the linking of IT solutions increasingly important. The Code of PLM Openness (CPO), developed by the ProSTEP iViP Association, supplies a concrete approach for achieving precisely that. Fraunhofer IAO has now developed an effective certification for companies, which helps them comply with the CPO criteria.
Industrie 4.0 requires intensified collaboration between various tools and systems. Only when…
eDataCenterAnalyzer Increases Transparency in Data Centers
30 June 2016. Walldorf, Germany. – fluid Operations™ AG (fluidOps), a leader in semantic technologies, today launched eDataCenterAnalyzer™, an app that increases transparency in data centers. With the launch of this app and new releases of its Smart Data Platform Information Workbench™ and cloud management app eCloudManager™, the company has set the cornerstone for the future development of its product portfolio.
eDataCenterAnalyzer combines the full functionality of Information Workbench with innovative…
Transparency across the entire process chain
Leitner Spedition implements best4log-x
• Austrian trucking company uses arvato Systems solution
• End-to-end process management provides higher efficiency
(arvato Systems) Gütersloh / Unterpremstätten – Since the beginning of 2015, the Austrian trucking company Leitner Spedition has been working with the best4log-x transport management system. This SAP-based solution from arvato Systems provides an integrated digital information flow and supports mid-sized companies in achieving a transparent process design. Controlling and Reporting have seen a…
